Edit Patent fast and easy

Simple guide on the way to Edit Patent

Getting comprehensive control over your documents at any moment is essential to ease your everyday tasks and improve your efficiency. Achieve any goal with DocHub tools for papers management and practical PDF editing. Gain access, modify and save and integrate your workflows along with other safe cloud storage services.

Follow these basic steps to Edit Patent utilizing DocHub:

Sign in for your account or sign up for free using your Google account or email address.
Choose a document you need to upload from your computer or integrated cloud storage service (Box, Google Drive, or OneDrive).
Gain access to DocHub advanced editing tools with a user-friendly interface and change Patent in accordance with your needs.
Edit Patent and save adjustments.
Effortlessly correct any errors prior to going forward with your papers export.
Download, export and send out or conveniently share your papers along with your colleagues and customers.
Get back to your papers or create Templates to optimize your efficiency

DocHub offers you lossless editing, the chance to use any formatting, and safely eSign documents without the need of looking for a third-party eSignature alternative. Get the most from the document managing solutions in one place. Check out all DocHub capabilities right now with the free account.

PDF editing simplified with DocHub

Seamless PDF editing

Editing a PDF is as simple as working in a Word document. You can add text, drawings, highlights, and redact or annotate your document without affecting its quality. No rasterized text or removed fields. Use an online PDF editor to get your perfect document in minutes.

Smooth teamwork

Collaborate on documents with your team using a desktop or mobile device. Let others view, edit, comment on, and sign your documents online. You can also make your form public and share its URL anywhere.

Automatic saving

Every change you make in a document is automatically saved to the cloud and synchronized across all devices in real-time. No need to send new versions of a document or worry about losing information.

Google integrations

DocHub integrates with Google Workspace so you can import, edit, and sign your documents directly from your Gmail, Google Drive, and Dropbox. When finished, export documents to Google Drive or import your Google Address Book and share the document with your contacts.

Powerful PDF tools on your mobile device

Keep your work flowing even when you're away from your computer. DocHub works on mobile just as easily as it does on desktop. Edit, annotate, and sign documents from the convenience of your smartphone or tablet. No need to install the app.

Secure document sharing and storage

Instantly share, email, and fax documents in a secure and compliant way. Set a password, place your documents in encrypted folders, and enable recipient authentication to control who accesses your documents. When completed, keep your documents secure in the cloud.

Drive efficiency with the DocHub add-on for Google Workspace

Access documents and edit, sign, and share them straight from your favorite Google Apps.

Install now

How to Edit Patent

4.7 out of 5

32 votes

In this video, Mart, a PhD student in medicinal chemistry, expresses gratitude for reaching over 100 subscribers and discusses the significance of patents in the CRISPR field. He defines a patent as a legal document granting inventors exclusive rights to their new processes or equipment for a period, typically 20 years in the CRISPR domain. This exclusivity necessitates that anyone using the technology during this time must pay royalties to the patent holder. Mart highlights the importance of knowing who holds the rights to CRISPR technologies, mentioning two opposing sides: Nobel Prize winners Jennifer Doudna and Emmanuelle Charpentier, founders of CRISPR Therapeutics and Intellia, versus Fang Zhang.

Got questions?

Below are some common questions from our customers that may provide you with the answer you're looking for. If you can't find an answer to your question, please don't hesitate to reach out to us.

Contact us

What happened to the CRISPR patent?

On February 28, 2022, the Patent, Trial and Appeal Board (PTAB) issued a judgment and decision in the second interference involving claims to CRISPR-Cas9 systems for use in eukaryotic cells.

Who won the CRISPR patent Battle?

USPTO issued Broad a patent for CRISPR in April 2014, and the CVC the next year challenged that award in whats known as an interference. PTAB ruled in favor of Broad, and the CVC took the issue to federal court and lost again.

What does Editas medicine do?

Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.

Does Editas own CRISPR?

Editas Medicines foundational intellectual property includes issued patents covering fundamental aspects of both CRISPR/Cas9 and CRISPR/Cas12a gene editing. Editas Medicines patents broadly cover CRISPR/Cas9 and CRISPR/Cas12a gene editing in all human cells.

What is Editas working on?

Editas Medicine is working to develop genomic medicines for a range of diseases, many of which do not currently have medicines available. We are a gene editing company, and use the terms gene and genome editing interchangeably to refer to our CRISPR gene editing technology.

What is CRISPR used for in medicine?

CRISPR is a highly precise gene editing tool that is changing cancer research and treatment. Ever since scientists realized that changes in DNA cause cancer, they have been searching for an easy way to correct those changes by manipulating DNA.

Who owns the rights to CRISPR?

Harvards and MITs Broad Institute, which obtained the first CRISPR patent in 2014 and later obtained related patents, said the decision confirmed its patents were properly issued.

What companies own CRISPR?

5 best CRISPR stocks to buy CompanyMarket CapCRISPR Therapeutics (NASDAQ:CRSP)$6.1 billionEditas Medicine (NASDAQ:EDIT)$1.9 billionIntellia Therapeutics (NASDAQ:NTLA)$8.9 billionVerve Therapeutics (NASDAQ:VERV)$1.9 billion1 more row

Is Editas medicine a good stock to buy?

On average, Wall Street analysts predict that Editas Medicines share price could docHub $17.71 by Feb 1, 2024. The average Editas Medicine stock price prediction forecasts a potential upside of 81.68% from the current EDIT share price of $9.75.

Which company is leading in CRISPR?

7 CRISPR Stocks With the Best Long-Term Potential CRSPCRISPR Therapeutics$49.96NTLAIntellia Therapeutics$40.12VERVVerve Therapeutics$21.77CLLSCellectis$3.01SGMOSangamo Therapeutics$3.402 more rows Jan 30, 2023

See why our customers choose DocHub

Great solution for PDF docs with very little pre-knowledge required.

"Simplicity, familiarity with the menu and user-friendly. It's easy to navigate, make changes and edit whatever you may need. Because it's used alongside Google, the document is always saved, so you don't have to worry about it."

Pam Driscoll F
Teacher

A Valuable Document Signer for Small Businesses.

"I love that DocHub is incredibly affordable and customizable. It truly does everything I need it to do, without a large price tag like some of its more well known competitors. I am able to send secure documents directly to me clients emails and via in real time when they are viewing and making alterations to a document."

Jiovany A
Small-Business

I can create refillable copies for the templates that I select and then I can publish those.

"I like to work and organize my work in the appropriate way to meet and even exceed the demands that are made daily in the office, so I enjoy working with PDF files, I think they are more professional and versatile, they allow..."

Victoria G
Small-Business

be ready to get more

Edit and sign PDFfor free

Get started now

Edit Patent